SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-015925
Filing Date
2023-04-28
Accepted
2023-04-28 16:52:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A janx_defa14a_2023.htm DEFA14A 28881
2 GRAPHIC img201241914_0.jpg GRAPHIC 1542630
3 GRAPHIC img201241914_1.jpg GRAPHIC 132205
  Complete submission text file 0000950170-23-015925.txt   2334948
Mailing Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130
Business Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130 (858) 751-4493
Janux Therapeutics, Inc. (Filer) CIK: 0001817713 (see all company filings)

IRS No.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40475 | Film No.: 23867694
SIC: 2834 Pharmaceutical Preparations